InMode Ltd. (NASDAQ:INMD – Get Free Report)’s share price hit a new 52-week low on Thursday. The company traded as low as $12.61 and last traded at $12.6950, with a volume of 61,684 shares. The stock had previously closed at $12.88.
Wall Street Analysts Forecast Growth
INMD has been the topic of several recent research reports. Robert W. Baird cut their price target on InMode from $17.00 to $15.00 and set a “neutral” rating on the stock in a report on Thursday, November 12th. Weiss Ratings raised InMode from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday. One equities research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $16.33.
Get Our Latest Report on InMode
InMode Trading Down 1.1%
The firm’s 50-day simple moving average is $13.99 and its 200 day simple moving average is $14.25. The stock has a market cap of $732.37 million, a P/E ratio of 10.56 and a beta of 1.98.
InMode (NASDAQ:INMD – Get Free Report) last released its quarterly earnings results on Wednesday, November 11th. The healthcare company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.32 by $0.05. The company had revenue of $92.14 million for the quarter, compared to analysts’ expectations of $91.58 million. InMode had a return on equity of 11.55% and a net margin of 19.94%. The business’s revenue for the quarter was down 1.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.38 earnings per share.
Institutional Investors Weigh In On InMode
Hedge funds and other institutional investors have recently modified their holdings of the stock. IFP Advisors Inc acquired a new stake in InMode in the second quarter worth about $31,000. Parallel Advisors LLC increased its stake in shares of InMode by 43.3% during the third quarter. Parallel Advisors LLC now owns 4,934 shares of the healthcare company’s stock valued at $70,000 after acquiring an additional 1,490 shares during the period. Aquatic Capital Management LLC acquired a new position in shares of InMode during the third quarter valued at approximately $82,000. Hsbc Holdings PLC bought a new stake in InMode during the first quarter worth approximately $163,000. Finally, Signaturefd LLC raised its holdings in InMode by 50.0% during the third quarter. Signaturefd LLC now owns 12,014 shares of the healthcare company’s stock worth $170,000 after purchasing an additional 4,006 shares in the last quarter. 68.04% of the stock is currently owned by institutional investors.
About InMode
InMode Ltd. is an Israel-based medical technology company that develops energy-based systems for minimally invasive aesthetic and medical procedures. Its technologies use radiofrequency energy to support treatments such as body contouring, skin tightening and facial rejuvenation, as well as certain women’s health applications. The company’s product portfolio includes platforms and handpieces such as BodyTite and FaceTite for body and facial contouring, and Morpheus8 for fractional radiofrequency skin treatments.
Featured Stories
- Five stocks we like better than InMode
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
- 3 Niche ETFs Are Beating the S&P 500, and Their Strategies Are Anything but Typical
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.
